Results 311 to 320 of about 121,812 (366)

Guideline‐directed medical therapy rates in heart failure patients with reduced ejection fraction in a diverse cohort

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Guideline‐directed medical therapy (GDMT) is recommended for all patients with heart failure with reduced ejection fraction (HFrEF). Despite this, little data exist describing GDMT use in diverse, real‐world populations including the use of vasodilators, prescribed primarily to Black populations.
Natalia C. Berry   +4 more
wiley   +1 more source

Pro‐adrenomedullin as an independent predictive biomarker for heart failure in atrial fibrillation and flutter

open access: yesESC Heart Failure, EarlyView.
Abstract Aims This study aimed to investigate potential biomarkers for predicting incident heart failure (HF) in patients with atrial fibrillation and flutter (AF and AFL), utilizing proteomic data from the UK Biobank Pharma Proteomics Project (UKB‐PPP).
Gaifeng Hu   +8 more
wiley   +1 more source

Global trends and epidemiological impact of metabolic risk factors on atrial fibrillation and atrial flutter from 1990 to 2021. [PDF]

open access: yesSci Rep
Liang J   +10 more
europepmc   +1 more source

Severity of tricuspid regurgitation predicts risk of recurrence of atrial fibrillation after pulmonary vein isolation

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Tricuspid regurgitation (TR) results in right atrial remodelling, thus promoting the formation of a substrate for atrial fibrillation (AF). In turn, AF may cause TR by annulus dilatation. We investigated whether the presence of TR affects the efficacy of pulmonary vein isolation (PVI) for AF. Methods and results In patients undergoing PVI,
Jan Wintrich   +7 more
wiley   +1 more source

Relaxin mimetic in pulmonary hypertension associated with left heart disease: Design and rationale of Re‐PHIRE

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Despite receiving guideline‐directed medical heart failure (HF) therapy, patients with pulmonary hypertension associated with left heart disease (PH‐LHD) experience higher mortality and hospitalization rates than the general HF population.
Marcin Ufnal   +17 more
wiley   +1 more source

Ablation of Ventricular and Atrial Arrhythmias in the Era of Cardiac Magnetic Resonance. [PDF]

open access: yesEchocardiography
Costantini P   +20 more
europepmc   +1 more source

State of precision medicine for heart failure with preserved ejection fraction in a new therapeutic age

open access: yesESC Heart Failure, EarlyView.
Abstract Heart failure with preserved ejection fraction (HFpEF) is defined by heart failure (HF) with a left ventricular ejection fraction (LVEF) of at least 50%. HFpEF has a complex and heterogeneous pathophysiology with multiple co‐morbidities contributing to its presentation. Establishing the diagnosis of HFpEF can be challenging.
Roy Rasalam   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy